NCT03903432 (ESS) is a NA clinical trial of MRI in Chronic Sinusitis, sponsored by Roee Landsberg.

Who is sponsoring NCT03903432?

NCT03903432 is sponsored by Roee Landsberg.

What drugs are being tested in NCT03903432?

Interventions in NCT03903432: MRI.

What condition does NCT03903432 study?

NCT03903432 studies Chronic Sinusitis.

Is NCT03903432 still recruiting?

NCT03903432 is currently status unknown. Last updated 4 April 2019.

Last reviewed 2019-04-04 · How we verify

NCT03903432: ESS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Feasibility of Using MRI During ESS

Status unknown NA Last updated 4 April 2019

What this trial tests

NA trial testing MRI in Chronic Sinusitis in 45 participants. Status unknown.

Timeline

15 May 2019

Primary endpoint
15 February 2020

15 February 2021

Quick facts

Lead sponsor	Roee Landsberg
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	45
Start date	15 May 2019
Primary completion	15 February 2020
Estimated completion	15 February 2021
Sites	1 location across Israel

Drugs / interventions tested

MRI — full drug profile →

Conditions studied

Chronic Sinusitis — all drugs for Chronic Sinusitis →

Sponsor

Roee Landsberg

Who can join

18 and older, any sex, with Chronic Sinusitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Before performing endoscopic sinus surgery (ESS-Endoscopic Sinus Surgery), every candidate for surgery is referred to perform a sinus CT scan of the sinuses. Because of the complicated anatomy of the sinuses and their proximity to vital organs such as the brain, eye, and carotid artery, the surgeon use the CT imaging during surgery to adjust the anatomy and to avoid complications such as blindness, brain damage and massive bleeding (0.3%). Sometimes the CT is integrated into a navigation system, although there is no evidence that the use of navigation systems reduces the rate of complications. The aim of our study is to examine whether ESS can be performed in chronic sinusitis patients using MRI, with CT being used as a backup only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03903432 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Roee Landsberg
Last refreshed: 4 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03903432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing